BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22925134)

  • 1. Outcomes and prognostic factors in nodular melanomas.
    Egger ME; Dunki-Jacobs EM; Callender GG; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM
    Surgery; 2012 Oct; 152(4):652-9; discussion 659-60. PubMed ID: 22925134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique prognostic factors in acral lentiginous melanoma.
    Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
    Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and survival differences between upper and lower extremity melanomas.
    Egger ME; Tabler BL; Dunki-Jacobs EM; Callender GG; Scoggins CR; Martin RC; Quillo AR; Stromberg AJ; McMasters KM
    Am Surg; 2012 Jul; 78(7):779-87. PubMed ID: 22748538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    MandalĂ  M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of ulceration of cutaneous melanoma of the head and neck: a comparison of ear (pinna) and nonear sites.
    Augenstein AC; Capello ZJ; Little JA; McMasters KM; Bumpous JM
    Laryngoscope; 2012 Nov; 122(11):2468-72. PubMed ID: 23108883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
    Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
    Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; BĂ©atrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
    Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
    Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion as a prognostic factor in melanoma.
    Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
    Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is incisional biopsy of melanoma harmful?
    Martin RC; Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Edwards MJ; McMasters KM
    Am J Surg; 2005 Dec; 190(6):913-7. PubMed ID: 16307945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y; Otsuka F;
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
    Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
    J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.